Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $7.95 ($40K) on 2006-12-26, disclosed to the SEC on 2006-12-27.
Scheduled sale ($40k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.86 | 300 | $2K | 5.9% |
| 2 | $7.87 | 200 | $2K | 4.0% |
| 3 | $7.88 | 200 | $2K | 4.0% |
| 4 | $7.89 | 900 | $7K | 17.9% |
| 5 | $7.90 | 600 | $5K | 11.9% |
| 6 | $7.91 | 400 |
| $3K |
| 8.0% |
| 7 | $7.92 | 200 | $2K | 4.0% |
| 8 | $7.93 | 500 | $4K | 10.0% |
| 9 | $7.94 | 200 | $2K | 4.0% |
| 10 | $7.95 | 200 | $2K | 4.0% |
| 11 | $7.96 | 300 | $2K | 6.0% |
| 12 | $7.97 | 200 | $2K | 4.0% |
| 13 | $7.98 | 100 | $798 | 2.0% |
| 14 | $8.02 | 200 | $2K | 4.0% |
| 15 | $8.04 | 100 | $804 | 2.0% |
| 16 | $8.10 | 100 | $810 | 2.0% |
| 17 | $8.12 | 200 | $2K | 4.1% |
| 18 | $8.16 | 100 | $816 | 2.1% |
| Total | $7.94 avg | 5,000 | $40K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |